Novanta Inc. (Formerly Known As GSI Group)
125 Middlesex Turnpike
Bedford
Massachusetts
01730
United States
Tel: 781-266-5700
Fax: 781-266-5114
Website: http://www.gsig.com/
129 articles about Novanta Inc. (Formerly Known As GSI Group)
-
Novanta to Present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024
4/19/2024
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the William Blair 44th Annual Growth Stock Conference on Tuesday, June 4, 2024, in Chicago, IL.
-
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2023
2/28/2024
Novanta Inc. today reported financial results for the fourth quarter and full year 2023.
-
Novanta completes acquisition of Motion Solutions
1/2/2024
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that it has completed the acquisition of Motion Solutions.
-
Novanta to Present at the CJS Securities 24th Annual New Ideas for the New Year Investor Conference on Wednesday, January 10, 2024
12/13/2023
Novanta Inc. (Nasdaq: NOVT) (the "Company") announced today that Robert Buckley, Chief Financial Officer, Chuck Ravetto, Group President, and Ray Nash, Vice President, Corporate Finance, are scheduled to present at the CJS Securities 24th Annual New Ideas for the New Year Investor Conference on Wednesday, January 10, 2024, which is being held virtually.
-
Novanta announces agreement to acquire Motion Solutions
11/14/2023
Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the "Company") announced today that it has entered into a definitive agreement to acquire Motion Solutions, a leading provider of highly engineered integrated solutions, for cash consideration of $189 million, subject to customary purchase price adjustments and closing conditions, including applicable regulatory approvals.
-
Novanta Announces Financial Results for the Third Quarter 2023
11/7/2023
Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the third quarter 2023.
-
Novanta to Present at the Baird 2023 Global Industrial Conference on Wednesday, November 8, 2023
10/11/2023
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at the Baird 2023 Global Industrial Conference on Wednesday, November 8, 2023, in Chicago, Illinois.
-
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, November 7, 2023
10/10/2023
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2023 results on Tuesday, November 7, 2023.
-
Novanta to Present at Baird's 2023 Global Healthcare Conference on Wednesday, September 13, 2023
8/9/2023
Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at Baird's 2023 Global Healthcare Conference on Wednesday, September 13, 2023, in New York, New York.
-
Novanta Announces Financial Results for the Second Quarter 2023
8/8/2023
Novanta Inc. today reported financial results for the second quarter 2023.
-
Novanta receives Silver rating from EcoVadis
7/27/2023
Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, announced that the Company has received a Silver rating from EcoVadis for its sustainability practices.
-
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 8, 2023
7/11/2023
Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2023 results on Tuesday, August 8, 2023.
-
Novanta to Present at the CJS Securities 23rd Annual New Ideas Summer Conference on Tuesday, July 11, 2023
6/26/2023
Novanta Inc. (Nasdaq: NOVT) (the "Company") announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 23rd Annual New Ideas Summer Conference on Tuesday, July 11, 2023, in White Plains, New York.
-
Photo Research launches new SpectraScan™ PR-1050 Spectroradiometer, with highest levels of speed and sensitivity
5/23/2023
Photo Research, a Novanta Corporation brand, announces the release of the Photo Research SpectraScan™ PR-1050 Spectroradiometer.
-
Novanta to Present at Baird's 2023 Global Consumer, Technology & Services Conference on Wednesday, June 7, 2023
5/22/2023
Novanta Inc. announced that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled to present at Baird's 2023 Global Consumer, Technology & Services Conference on Wednesday, June 7, 2023, in New York, NY.
-
Novanta Announces Financial Results for the First Quarter 2023
5/9/2023
Novanta Inc., a trusted technology partner to medical and advanced technology equipment manufacturers, reported financial results for the first quarter 2023.
-
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 9, 2023
4/11/2023
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2023 results on Tuesday, May 9, 2023.
-
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2022
3/1/2023
Novanta Inc. today reported financial results for the fourth quarter and full year 2022.
-
Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, March 1, 2023
2/1/2023
Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its fourth quarter and full year 2022 results on Wednesday, March 1, 2023.
-
Novanta to Present at the CJS Securities 23rd Annual New Ideas for the New Year Investor Conference on Wednesday, January 11, 2023
12/13/2022
Novanta Inc. (Nasdaq: NOVT) (the "Company") announced today that Robert Buckley, Chief Financial Officer, and Chuck Ravetto, Group President, are scheduled to present at the CJS Securities 23rd Annual New Ideas for the New Year Investor Conference on Wednesday, January 11, 2023, which is being held virtually.